Steroidal Pyrimidines and Dihydrotriazines as Novel Classes of Anticancer Agents against Hormone-Dependent Breast Cancer CellsAlexander M. Scherbakov, Yulia A. Volkova|Frontiers in Pharmacology|2018Cited by 65
The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signalingAlexander M. Scherbakov, Krasil'nikov Ma|IUBMB Life|2016Cited by 60
Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cellsAlexander M. Scherbakov, Валерий З. Ширинян|Investigational New Drugs|2023Cited by 29
Targeting hormone-resistant breast cancer cells with docetaxel: a look inside the resistanceAlexander M. Scherbakov, Krasil'nikov Ma|Cancer Drug Resistance|2023Cited by 18
Honokiol inhibits the growth of hormone-resistant breast cancer cells: its promising effect in combination with metforminEkaterina I. Mikhaevich, Alexander M. Scherbakov|Research in Pharmaceutical Sciences|2023Cited by 10